Indeed, our results showed that LTF knockdown robustly promoted the metastatic potentials of ccRCC cells but conversely rendered those cells sensitive to the treatment of mTOR inhibitor rapamycin. The gene discussed is MTOR; the disease is nonpapillary renal cell carcinoma.